Sex Differences in Risk Factors for HIV Seroconversion Among Injection Drug Users: A 10-Year Perspective
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Injection drug use directly or indirectly accounts for nearly half the annual human immunodeficiency virus (HIV) infections in the United States. Prospective studies that investigate both sexual and parenteral HIV risks among injection drug users (IDUs) are needed. We studied factors for HIV seroconversion among male and female IDUs in Baltimore, Md. METHODS: The HIV-negative IDUs (1447 male and 427 female) were recruited into a prospective study from 1988 to 1989 or in 1994. Participants underwent semiannual HIV tests and surveys through December 1998. Poisson regression was used to identify risk factors for HIV seroconversion, stratified by sex. Behaviors were treated as time-dependent covariates that varied at each semiannual period. RESULTS: Subjects were primarily African American (91%), and median age at enrollment was 35 years. Incidence of HIV was 3.14 per 100 person years (95% confidence interval, 2.78-3.53) and did not significantly differ by sex. Younger age independently predicted HIV seroconversion for both men and women. Among men, factors that independently predicted HIV seroconversion were the following: less than a high school education, recent needle sharing with multiple partners, daily injection, and shooting-gallery attendance. The incidence of HIV was double for men recently engaging in homosexual activity and cocaine injection. Among women, the incidence of HIV was more than double for those recently reporting sexually transmitted diseases. CONCLUSIONS: The incidence of HIV remained high among IDUs in Baltimore over the past decade. Risk factors for HIV seroconversion differed markedly by sex. Predominant risks among men included needle sharing and homosexual activity; among women, factors consistent with high-risk heterosexual activity were more significant than drug-related risks. Human immunodeficiency virus interventions aimed at IDUs should be sex-specific and incorporate sexual risks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Cameron, D. W., D'Costa, L., Maitha, G., Cheang, M., Piot, P., Simonsen, J. N., Ronald, A., Gakinya, M., Ndinya-Achola, J. O., Brunham, R., et al. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90589-8 · Cited by 753
Cofactors in Male-Female Sexual Transmission of Human Immunodeficiency Virus Type 1
Plummer, F. A., Simonsen, J. N., Cameron, D. W., Ndinya-Achola, J. O., Kreiss, J. K., Gakinya, M. N., Waiyaki, P., Cheang, M., Piot, P., Ronald, A. R., et al. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.2.233 · Cited by 707
Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV
Taha, T. E., Hoover, D. R., Dallabetta, G. A., Kumwenda, N. I., Mtimavalye, L. A. R., Yang, L.-P., Liomba, G. N., Broadhead, R. L., Chiphangwi, J. D., & Miotti, P. G. (1998) · AIDS · doi:10.1097/00002030-199813000-00019 · Cited by 634
Cocaine Use and HIV Infection in Intravenous Drug Users in San Francisco
Chaisson, R. E. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420040099027 · Cited by 587
The estimated prevalence and incidence of HIV in 96 large US metropolitan areas.
Holmberg, S. D. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.5.642 · Cited by 539
Metzger, D. S., WOODY, G. E., McLellan, A. T., O’Brien, C. P., Druley, P., Navaline, H. A., DePhilippis, D., Stolley, P. D., & Abrutyn, E. (1993) · PubMed · Cited by 530
Risk Factors for Human Immunodeficiency Virus Infection in Intravenous Drug Users
Schoenbaum, E. E., Hartel, D., Selwyn, P. A., Klein, R. S., Davenny, K., Rogers, M., Feiner, C., & Friedland, G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909283211306 · Cited by 494
HIV incidence among injecting drug users in New York City syringe-exchange programmes
Jarlais, D. C. D., Marmor, M., Paone, D., Titus, S., Shi, Q., Perlis, T., Jose, B., & Friedman, S. R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02536-6 · Cited by 406
Prior Herpes Simplex Virus Type 2 Infection as a Risk Factor for HIV Infection
Holmberg, S. D. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03720070048033 · Cited by 367
Cited by
Madras, B. K., Compton, W. M., Avula, D., Stegbauer, T., Stein, J. B., & Clark, H. W. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.003 · Cited by 663
“…2007; yenwe et al., 2007; O’Malley and Johnston, 2003; Rivara t al., 1997; Rootman et al., 2007; Shoptaw and Reback, 007; Stein and Friedmann, 2006; Strathdee et al., 2001; ullivan et al., 2005; Swanson et al., 2007; Sweeney et al., 000; Volkow et al., 2007; Westover et al., 2007; Wilson nd…”
BackgroundHIV and risk environment for injecting drug users: the past, present, and future
Strathdee, S. A., Hallett, T. B., Bobrova, N., Rhodes, T., Booth, R., Abdool, R., & Hankins, C. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60743-x · Cited by 559
Self-citationAspinall, E. J., Nambiar, D., Goldberg, D. J., Hickman, M., Weir, A., Van Velzen, E., Palmateer, N., Doyle, J. S., Hellard, M. E., & Hutchinson, S. J. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt243 · Cited by 399
Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis
Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., & Edlin, B. R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04562-1 · Cited by 352
HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention.
Latkin, C. A., Sherman, S., & Knowlton, A. (2003) · Health Psychology · doi:10.1037/0278-6133.22.4.332 · Cited by 348
The Everyday Violence of Hepatitis C among Young Women Who Inject Drugs in San Francisco
Bourgois, P., Prince, B., & Moss, A. (2004) · Human Organization · doi:10.17730/humo.63.3.h1phxbhrb7m4mlv0 · Cited by 318
Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users
Latkin, C. A., Forman, V., Knowlton, A., & Sherman, S. (2003) · Social Science & Medicine · doi:10.1016/s0277-9536(02)00047-3 · Cited by 303
Marital status and longevity in the United States population
Kaplan, R. M., & Kronick, R. G. (2006) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2005.037606 · Cited by 297
Oral substitution treatment of injecting opioid users for prevention of HIV infection
Gowing, L., Farrell, M. F., Bornemann, R., Sullivan, L. E., & Ali, R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004145.pub4 · Cited by 296
The Role of Sexual Transmission of HIV Infection Among Injection and Non-Injection Drug Users
Strathdee, S. A. (2003) · Journal of Urban Health: Bulletin of the New York Academy of Medicine · doi:10.1093/jurban/jtg078 · Cited by 281
Self-citationWood, E. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040774 · Cited by 267
Rhodes, T., Wagner, K., Strathdee, S. A., Shannon, K., Davidson, P., & Bourgois, P. (2012) · Rethinking Social Epidemiology · doi:10.1007/978-94-007-2138-8_10 · Cited by 220
Self-citationIversen, J., Page, K., Madden, A., & Maher, L. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000659 · Cited by 189
Margolin, A., Avants, S. K., Warburton, L. A., Hawkins, K. A., & Shi, J. (2003) · Health Psychology · doi:10.1037//0278-6133.22.2.223 · Cited by 173
Garfein, R. S., Golub, E. T., Greenberg, A. E., Hagan, H., Hanson, D. L., Hudson, S. M., Kapadia, F., Latka, M. H., Ouellet, L. J., Purcell, D. W., et al. (2007) · AIDS · doi:10.1097/qad.0b013e32823f9066 · Cited by 159
Self-citationDo Supervised Injecting Facilities Attract Higher-Risk Injection Drug Users?
Wood, E., Tyndall, M. W., Li, K., Lloyd-Smith, E., Small, W., Montaner, J. S. G., & Kerr, T. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.04.011 · Cited by 122
Wood, E., Kerr, T., Lloyd-Smith, E., Buchner, C., Marsh, D. C., Montaner, J. S., & Tyndall, M. W. (2004) · Harm Reduction Journal · doi:10.1186/1477-7517-1-9 · Cited by 107
Green, T. C., Kershaw, T., Lin, H., Heimer, R., Goulet, J. L., Kraemer, K. L., Gordon, A. J., Maisto, S. A., Day, N. L., Bryant, K., et al. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.02.020 · Cited by 101
Metadata
- Authors
- Strathdee, S. A., Galai, N., Safaiean, M., Celentano, D. D., Vlahov, D., Johnson, L., & Nelson, K. E.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2001-05-28
- Volume
- 161
- Issue
- 10
- Pages
- 1281
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2012389503
- Cited by
- 331
- References
- 38
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.